⌘K

Login Start Free

Home/Filings/4/0001140361-24-037705

4//SEC Filing

Ying Han 4

Accession 0001140361-24-037705

CIK 0001124105other

View on SEC.gov Company Profile

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 8:50 PM ET

Size

5.5 KB

Accession

0001140361-24-037705

Insider Transaction Report

Form 4

Period: 2024-08-14

GYRE THERAPEUTICS, INC.GYRE

Director

Transactions

Award
Stock Option (Right to Buy)
2024-08-14+341,000→ 341,000 total
Exercise: $9.98Exp: 2034-08-14→ Common Stock (341,000 underlying)

Footnotes (1)

[F1]This option represents a right to purchase a total of 341,000 shares of the Issuer's common stock, 25% of which will vest on August 14, 2025, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

GYRE THERAPEUTICS, INC.

CIK 0001124105

Entity typeother

Related Parties

1

filerCIK 0001987630

Filing Metadata

Form type: 4
Filed: Aug 15, 8:00 PM ET
Accepted: Aug 16, 8:50 PM ET
Size: 5.5 KB

View on SEC.gov